maltotetraose has been researched along with Glycogen Storage Disease Type II in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Vries, JM; Goudriaan, DA; Huijmans, JG; Reuser, AJ; Ruijter, GJ; Sluiter, W; van den Bosch, JC; van der Ploeg, AT; van Gelder, CM | 1 |
1 other study(ies) available for maltotetraose and Glycogen Storage Disease Type II
Article | Year |
---|---|
Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Chromatography, Liquid; Glycogen; Glycogen Storage Disease; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type IV; Humans; Infant; Infant, Newborn; Maltose; Middle Aged; Oligosaccharides; Reference Values; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Young Adult | 2012 |